EP Biocomposites Limited (BOM:543595)
India · Delayed Price · Currency is INR 133.00
+10.60 (8.66%)
At close: Aug 7, 2025
EP Biocomposites Revenue
In the fiscal year ending March 31, 2025, EP Biocomposites had annual revenue of 120.06M INR with 4.96% growth. EP Biocomposites had revenue of 76.01M in the half year ending March 31, 2025, with 106.65% growth.
Revenue
120.06M
Revenue Growth
+4.96%
P/S Ratio
1.86
Revenue / Employee
n/a
Employees
51
Market Cap
223.64M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 120.06M | 5.67M | 4.96% |
| Mar 31, 2024 | 114.39M | 43.09M | 60.42% |
| Mar 31, 2023 | 71.31M | -9.29M | -11.52% |
| Mar 31, 2022 | 80.60M | 51.12M | 173.39% |
| Mar 31, 2021 | 29.48M | -4.62M | -13.54% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,839.41B |
| Tata Consultancy Services | 2,561.48B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,503.84B |
| Infosys | 1,672.76B |
| Hindustan Unilever | 639.28B |